Clinical Trial Update: Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer [NA]

View source ↗

Summary

A bioequivalence study of nab-paclitaxel (paclitaxel albumin-bound) for injection in subjects with breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd | Conditions: Breast Cancer | NA | Status: RECRUITING